Genetic Epidemiology I
Genetic Epidemiology I
Fundamentals, Theory, Practice and Latest Developments
21 seminar style audio visual talks presented by leading world experts
Purchase Information
Target Audience
For everyone wishing to know the latest developments, opportunities and complexities in Genetic Epidemiology, relevant to the pharmaceutical and biotechnology industries.
Series Editor
Dr. Mike Weale, Duke Institute for Genome Sciences & Policy, North Carolina, USA.
Participating Speakers
Prof. Chris Amos, Prof. David Balding, Prof. Chris Cannings, Prof. David Clayton, Dr. Andrew Collins, Prof. Peter Donnelly, Prof. Robert Elston, Prof. David Goldstein, Prof. Steve Jones, Dr. Andrew Morris, Prof. Newton Morton, Dr. Jonathan Pritchard, Prof. Michael Province, Prof. Pak Sham, Dr. Dawn Teare, Prof. Alun Thomas, Prof. Duncan Thomas and Prof. Bruce Weir.
Topics Covered
Basic Genetics – Population Genetics – Segregation Analysis – Genetic Linkage Analysis – Study Design – Genome Wide Scans – Sample Size Issues – Heterogeneity – Haplotype Phase Inference – Graphic Modelling – Modelling Complex Metabolic Pathways – Models and Methods for Association Mapping – Correcting for Population Structure – DNA Pooling – Haplotype Tagging SNPs – Pharmacogenetics.
The Format
Each of the seminars is specially commissioned from a leading world expert in a user friendly format of animated slides with synchronized narration. The talks preserve each speaker’s personality and approach allowing you to experience world class seminars at your own pace, wherever you want and as often as you want.
"These talks, presented by the world’s leading experts, enable the non-specialist and specialist alike to immerse themselves in the latest and best thinking in genomic epidemiology. The specialist can go straight to the frontier, listening to leading edge briefings, while the new entrant can start at the beginning and be briefed at a pace suitable to themselves. I cannot recommend this series too highly - they are essential listening."
Prof. James Scott, Chief Executive of Imperial College Genetics and Genomics Research Institute, London, UK